Wakefield Asset Management’s CVS Health CVS Stock Holding History

Wakefield Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,497	Closed	-$326K	–	170
2022 Q4	$326K	Buy	3,497 +15	+0.4%	+$1.45K	0.14%	145
2022 Q3	$332K	Sell	3,482 -303	-8%	-$30K	0.15%	134
2022 Q2	$351K	Buy	3,785 +889	+31%	+$86.8K	0.15%	135
2022 Q1	$293K	Sell	2,896 -275	-9%	-$28.9K	0.11%	155
2021 Q4	$327K	Buy	3,171 +174	+6%	+$16.1K	0.11%	148
2021 Q3	$254K	Sell	2,997 -37	-1%	-$3.1K	0.1%	149
2021 Q2	$253K	Buy	+3,034	New	+$248K	0.1%	150
2020 Q4	–	Sell	-3,490	Closed	-$204K	–	167
2020 Q3	$204K	Buy	3,490 +12	+0.3%	+$747	0.1%	153
2020 Q2	$226K	Buy	+3,478	New	+$219K	0.11%	147
2019 Q1	–	Sell	-18,511	Closed	-$1.21M	–	215
2018 Q4	$1.21M	Buy	+18,511	New	+$1.38M	0.52%	62

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wakefield Asset Management's CVS Position: Q1 2023 in Review

Wakefield Asset Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 3,497 shares — an estimated $326K sold.

Wakefield Asset Management first reported a position in CVS in Q4 2018 and held it in 10 quarters. The position peaked at $1.21M in Q4 2018. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Wakefield Asset Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Wakefield Asset Management sold 3,497 CVS Health shares in Q1 2023, an estimated $326K.
Wakefield Asset Management first reported a position in CVS Health in Q4 2018 and held it in 10 quarters.
Wakefield Asset Management's CVS Health position peaked at $1.21M in Q4 2018.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Wakefield Asset Management's 13F filing for Q1 2023, filed 2 May 2023.